Ardelyx reported $127.27M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Abbott USD 10.46B 1.15B Jun/2026
Amgen USD 11.69B 6.9B Jun/2026
Ardelyx USD 127.27M 7.15M Mar/2026
aTyr Pharma USD 2.42M 83.19M Mar/2026
Corcept Therapeutics USD 214.85M 343K Jun/2026
Curis USD 11.52M 2.5M Mar/2026
Sanofi EUR 8.98B 1.73B Mar/2026
TG Therapeutics USD 218.66M 48.54M Jun/2026
United Therapeutics USD 6.4B 499.2M Jun/2026